Noah Medical is a leading medical technology company that specializes in the development and manufacturing of advanced medical devices and equipment.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/19/2023 | Series B-1 | $150MM | $xx.xx | $1.16B | 1955 Capital, Ame Cloud Ventures, Hillhouse, Lyfe Capital, Prosperity7 Ventures, Sequoia China, Shangbay Capital, Softbank, Sunmed Capital, Tiger Global, Uphonest Capital | |
Price per Share
$xx.xx
Shares Outstanding
12,670,737
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
1955 Capital, Ame Cloud Ventures, Hillhouse, Lyfe Capital, Prosperity7 Ventures, Sequoia China, Shangbay Capital, Softbank, Sunmed Capital, Tiger Global, Uphonest Capital
|
||||||
01/10/2022 | Series B | $149.45MM | $xx.xx | $893.88MM | Ying Fund | |
Price per Share
$xx.xx
Shares Outstanding
13,673,599
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ying Fund
|
||||||
02/15/2020 | Series A | $61.69MM | $xx.xx | $365.34MM | Shangbay Capital, Uphonest Capital | |
Price per Share
$xx.xx
Shares Outstanding
25,703,557
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.9%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Shangbay Capital, Uphonest Capital
|
||||||
02/15/2020 | Series A-2 | $75.15MM | $xx.xx | $365.34MM | Shangbay Capital, Uphonest Capital | |
Price per Share
$xx.xx
Shares Outstanding
13,408,848
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Shangbay Capital, Uphonest Capital
|